Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Sep 15, 2020; 12(9): 1014-1030
Published online Sep 15, 2020. doi: 10.4251/wjgo.v12.i9.1014
Published online Sep 15, 2020. doi: 10.4251/wjgo.v12.i9.1014
Table 2 Clinical characteristics of the patients according to gamma-glutamyl transferase–to–platelet ratio
| Patients | GPR ≤ 0.365, n (%) | GPR > 0.365, n (%) | P value |
| Age, yr | 0.661 | ||
| ≤ 60 | 34 (37) | 13 (33) | |
| > 60 | 57 (63) | 26 (67) | |
| Gender | 0.484 | ||
| Male | 55 (60) | 21 (54) | |
| Female | 36 (40) | 18 (46) | |
| Jaundice | < 0.001 | ||
| No | 87 (96) | 24 (62) | |
| Yes | 4 (4) | 15 (38) | |
| Gallbladder stone | 0.319 | ||
| No | 45 (49) | 23 (59) | |
| Yes | 46 (51) | 16 (41) | |
| Liver disease | 0.509 | ||
| No | 81 (89) | 37 (95) | |
| Yes | 10 (11) | 2 (5) | |
| Differentiation stage of cancer cells | 0.640 | ||
| Low | 14 (18) | 7 (23) | |
| Low-medium | 18 (23) | 7 (23) | |
| Medium | 18 (23) | 8 (26) | |
| Medium-high | 16 (21) | 3 (10) | |
| High | 12 (15) | 6 (19) | |
| TNM stage | 0.053 | ||
| I + II | 23 (25) | 4 (10) | |
| III + IV | 68 (75) | 35 (90) | |
| BMI, kg/m2 | < 0.001 | ||
| ≥ 22.5 | 60 (73) | 11 (34) | |
| < 22.5 | 22 (27) | 21 (66) | |
| CEA, ng/mL | 0.732 | ||
| ≤ 5.30 | 56 (76) | 21 (72) | |
| > 5.30 | 18 (24) | 8 (28) | |
| CA19-9, U/mL | 0.049 | ||
| ≤ 47.8 | 47 (58) | 14 (38) | |
| > 47.8 | 35 (42) | 23 (62) | |
| Maximal tumor diameter, cm | 0.940 | ||
| ≤ 2.90 | 44 (50) | 20 (53) | |
| > 2.90 | 44 (50) | 18 (47) | |
- Citation: Sun LJ, Guan A, Xu WY, Liu MX, Yin HH, Jin B, Xu G, Xie FH, Xu HF, Du SD, Xu YY, Zhao HT, Lu X, Sang XT, Yang HY, Mao YL. γ-glutamyl transferase-to-platelet ratio based nomogram predicting overall survival of gallbladder carcinoma. World J Gastrointest Oncol 2020; 12(9): 1014-1030
- URL: https://www.wjgnet.com/1948-5204/full/v12/i9/1014.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i9.1014